Citigroup Nears Regulatory Approval for 25% Banamex Stake Sale
ZACKS· 2025-12-15 17:36
Key Takeaways Mexican regulators are close to approving Citigroup's 25% Banamex stake sale to Fernando Chico Pardo.The $2.3B deal supports Citigroup's deconsolidation of its Mexican consumer banking operations.Transaction advances C's plan for a future Banamex IPO and broader global transformation.Mexican financial regulators are nearing approval of Citigroup Inc.'s (C) planned sale of a 25% stake in its retail banking unit, Grupo Financiero Banamex, according to a Bloomberg News report, which was published ...
Hedera Slides to Lowest Point in a Year as Crypto Market Plunges
Yahoo Finance· 2025-12-15 17:36
Hedera plunged through key support levels during Sunday's session, declining 5.8% from $0.1202 to $0.1127 as technical selling pressure overwhelmed early buying interest. The cryptocurrency established a clear bearish structure after failing to hold gains above $0.1218, with price action dominated by profit-taking near resistance levels. Volume patterns told the story of capital flows throughout the session. Trading activity exploded to 69.18 million tokens on Dec. 14 at 20:00 UTC, marking an 86% surge ...
Radiopharm (RADX) Sees Slight Pessimism From Analysts
Yahoo Finance· 2025-12-15 17:35
We recently published 7 Best ASX Stocks to Buy Right Now. Radiopharm Theranostics Limited (NASDAQ:RADX) is one of the best ASX stocks. Radiopharm Theranostics Limited (NASDAQ:RADX) is a biotechnology company developing treatments for ailments such as brain metastasis and prostate cancer. B. Riley lowered its share price target for the firm to $13 from $15 and kept a Buy rating for the shares on November 26th. As part of its coverage, the research firm discussed Radiopharm Theranostics Limited (NASDAQ:RAD ...
Immutep (IMMP) Scores Win After Announcing Deal With Indian Firm
Yahoo Finance· 2025-12-15 17:35
We recently published 7 Best ASX Stocks to Buy Right Now. Immutep Limited (NASDAQ:IMMP) is one of the best ASX stocks. Immutep Limited (NASDAQ:IMMP) is a biotechnology company developing therapies for cancer and autoimmune diseases. The firm’s shares underwent notable traction earlier this week after Indian firm Dr. Reddy’s Laboratories Ltd.’s subsidiary entered into an agreement with its subsidiary to develop and commercialize a drug outside countries in North America, Europe, Japan, and Greater China. ...
Mesoblast (MESO) Sees Optimism From Analysts
Yahoo Finance· 2025-12-15 17:35
We recently published 7 Best ASX Stocks to Buy Right Now. Mesoblast Limited (NASDAQ:MESO) is one of the best ASX stocks. Mesoblast Limited (NASDAQ:MESO) is a biotechnology company developing treatments for inflammatory diseases, heart failure, and other ailments. On November 25th, Jefferies upgraded the firm’s shares to Buy from Hold and increased the share price target to AUD3.30 from AUD3.00. The financial firm cited Mesoblast Limited (NASDAQ:MESO)’s Ryoncil drug as the reason behind its optimism. Jeff ...
Oracle stock remains under pressure, but this analyst sees the stock climbing around 100%
Invezz· 2025-12-15 17:35
Oracle stock came under renewed pressure on Monday, extending a bruising selloff that has weighed heavily on the stock for several weeks. The cloud computing giant has lost more than 15% over the past five days, following a steep 23.1% drop in November that erased gains sparked by its blockbuster September earnings report. The stock's decline reflects a sharp reversal in sentiment after Oracle stunned investors earlier this year by revealing that its total backlog had more than quadrupled to $455 billion. T ...
Lidar-maker Luminar files for bankruptcy
TechCrunch· 2025-12-15 17:34
Lidar company Luminar has filed for Chapter 11 bankruptcy protection after months of layoffs, executive departures, and a legal fight with its largest customer, Volvo. The company aims to sell off its lidar business during the bankruptcy proceeding, and has already reached a deal to sell its semiconductor subsidiary. While the company will continue to operate during the bankruptcy process to “minimize disruptions” for its suppliers and customers, Luminar will eventually cease to exist once it’s completed. ...
Telix Pharma (TLX) Makes Progress With New Study
Yahoo Finance· 2025-12-15 17:34
We recently published 7 Best ASX Stocks to Buy Right Now. Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best ASX stocks. Telix Pharmaceuticals Limited (NASDAQ:TLX) is a biotechnology company developing treatments for ailments such as prostate and kidney cancer. The firm’s prostate cancer therapy candidate TLX591 is currently in a phase three study. On this front, Telix Pharmaceuticals Limited (NASDAQ:TLX) shared important news on December 8th when it announced that it had dosed the first patie ...
Woodside Energy (WDS) Secures Strong Position In Bidding
Yahoo Finance· 2025-12-15 17:34
We recently published 7 Best ASX Stocks to Buy Right Now. Woodside Energy Group Ltd (NYSE:WDS) is one of the best ASX stocks. Woodside Energy Group Ltd (NYSE:WDS) is an Australian oil and gas exploration and production company. The firm was at the center of an intense and crucial oil and gas drilling rights bidding process on December 10th. According to Reuters, Woodside Energy Group Ltd (NYSE:WDS), along with oil giants Chevron and BP, came out on top of the US government’s first drilling rights sale fo ...
Nvidia: H200 China Sales And The Margin Tradeoff (NASDAQ:NVDA)
Seeking Alpha· 2025-12-15 17:34
Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...